News Discover the latest news stories, blog posts and publications from Cobra's expert team. You are here: Home News Toggle filters Year: All Years 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 or Month: All Months January February March April May June July August September October November December or Type: All Categories DNA Fill Finish General DNA Proteins Technologies Viral Vectors Cobra and Lancaster partnership helps unravel new analytical tool for DNA topology DNA Lorna Ashton from Lancaster University working with Cobra Biologics to assess a novel method for determining the topology of plasmid DNA. BLOG: The Translation of Next Generation Therapeutics General Tony Hitchcock's Pharma IQ Blog Cobra & CPI to Collaborate on Regenerative Medicine Viral Vectors A project which will focus on the development of an Industrial Manufacturing Platform for Adeno-Associated Virus (AAV) production to support gene therapy and regenerative medicine.... Sheffield University approves Cobra Biologics to advance Growth Hormone antagonist Cobra Biologics Appointed by University of Sheffield to Advance Novel Fusion Protein Technology into Phase 1 Clinical Trials Cobra Biologics and The University of Manchester Announce Collaboration to Improve Industrial Scale-up Proteins Agreement brings together academic and industrial expertise for the scaled manufacture of therapeutic proteins BLOG: Fit for Purpose DNA Processes - Interesting dilemas from a manufacturing perspective Contract Biomanufacturing Firms Become More Specialized General Article by Randi Hernandez in BioPharm International Journal, Vol 28, Issue 9 with contribution by Daniel Smith - Chief Scientific Officer, Cobra Biologics BLOG: Expanding DNA Market DNA In the last 2-3 years there has been a very marked increase in interest in the use of plasmid DNA. BLOG: Moving Forward Together Recent common themes are the challenges of producing small volume products down to patient specific medicines and that of affordability of new products and patient access to new me... Developing a Cell Line Cobra have recently developed a cell line for Alligator Bioscience. Jack Rudd, Editor for Technology Networks talks to Cobra's Philip Ridley-Smith to learn more about the work carr... Alligator Bioscience AB Phase 1 Trial Benefits from Cobra Biologics' maxXpress Platform Alligator Bioscience AB Phase 1 Trial in Advanced Solid Tumours Benefits from Cobra Biologics' maxXpress Platform in Manufacturing Immuno-Oncology Antibody ADC-1013 Pagination Go to Previous page Go to page 6 Go to page 7 Go to page 8 Go to page 9 Go to page 10
Cobra and Lancaster partnership helps unravel new analytical tool for DNA topology DNA Lorna Ashton from Lancaster University working with Cobra Biologics to assess a novel method for determining the topology of plasmid DNA.
Cobra & CPI to Collaborate on Regenerative Medicine Viral Vectors A project which will focus on the development of an Industrial Manufacturing Platform for Adeno-Associated Virus (AAV) production to support gene therapy and regenerative medicine....
Sheffield University approves Cobra Biologics to advance Growth Hormone antagonist Cobra Biologics Appointed by University of Sheffield to Advance Novel Fusion Protein Technology into Phase 1 Clinical Trials
Cobra Biologics and The University of Manchester Announce Collaboration to Improve Industrial Scale-up Proteins Agreement brings together academic and industrial expertise for the scaled manufacture of therapeutic proteins
Contract Biomanufacturing Firms Become More Specialized General Article by Randi Hernandez in BioPharm International Journal, Vol 28, Issue 9 with contribution by Daniel Smith - Chief Scientific Officer, Cobra Biologics
BLOG: Expanding DNA Market DNA In the last 2-3 years there has been a very marked increase in interest in the use of plasmid DNA.
BLOG: Moving Forward Together Recent common themes are the challenges of producing small volume products down to patient specific medicines and that of affordability of new products and patient access to new me...
Developing a Cell Line Cobra have recently developed a cell line for Alligator Bioscience. Jack Rudd, Editor for Technology Networks talks to Cobra's Philip Ridley-Smith to learn more about the work carr...
Alligator Bioscience AB Phase 1 Trial Benefits from Cobra Biologics' maxXpress Platform Alligator Bioscience AB Phase 1 Trial in Advanced Solid Tumours Benefits from Cobra Biologics' maxXpress Platform in Manufacturing Immuno-Oncology Antibody ADC-1013